Accueil   Diary - News   All news Eveon announces the signature of a new agreement

Eveon announces the signature of a new agreement

EVEON, designer and manufacturer of medical devices for the preparation and/or administration of drugs, has announced the signature of a new agreement with a European pharmaceutical laboratory for the treatment of urinary incontinence using cell therapy.

Eveon will develop a new custom-made injection device for the administration of a cell therapy treatment currently in phase 3. Control of cell implantation and simple use are key to the development of this new product. This is why Eveon has been chosen by a European pharmaceutical laboratory to supply a specific solution, enabling surgeons to accurately implant cells while controlling the dose injected.

 

Read the press release